Editorial Board
Ohio University, USA
| Biography Prof. Tadeusz Malinski received his PhD in Biotechnology/Biochemistry from Poznan University of Technology. Dr. Malinski is the Marvin White Chair and Distinguished Professor at Ohio University. Malinski’s research focuses on nanomedicine, biochemistry and pharmacology. He developed nanosensors and nanodevices to monitor in situ, in vitro, and in vivo biochemical processes in single cells. These nanosystems can be used for the early medical diagnosis and treatment of neurodegenerative and cardiovascular diseases. Dr. Malinski’s work appears in more than 250 scientific journal articles. Research Interest
|  |
QuantiScientifics LLC, USA
| Biography Dr. Bob Matson is President and Co-Founder of QuantiScientifics, LLC. The company is involved in the commercialization of multiplexed assays for life science, clinical research and in vitro diagnostics. Previously, Bob was involved in the research and development of microarray technologies, detection chemistries, as well as, point of care devices for more than 17 years while at Beckman Coulter, Inc. He participated in NIST’s Advanced Technology Program sponsored Genosensor Consortium; and collaborated with Sir Edwin Southern on the development of an in situ oligonucleotide array synthesis platform for the corporation. Other work included development of the A2 MicroArray System, a microplate-based array platform for multiplexed micro-ELISA, which QuantiScientifics has licensed from Beckman Coulter.Dr. Matson has been granted 18 patents on nucleic acid and protein microarray technology. He was inducted into Beckman Coulter’s Inventors Hall of Fame in 2006; was elected a Fellow of the National Academy of Clinical Biochemistry in 2008; and is the 2014 Distinguished Alumnus, College of Science & Technology, Western Washington University. He is the author of Applying Genomic and Proteomic Microarray Technology in Drug Discovery-2nd Edition (CRC Press, 2013) and Microarray Methods and Protocols (CRC Press, 2009). He recently served as a guest editor for Current Opinion in Chemical Biology: Arrays (2014, Vol. 18). Research Interest Dr. Matson is currently involved in the development of high sensitivity multiplexing technologies with mobile connectivity for mHealth such as point of use or point of care environments. |  |
University of Bedfordshire, Luton, England
| Biography Dr. Barbara Guinn is an Associate Professor at the University of Bedfordshire and the Academic Director of Undergraduate Life Sciences. Dr. Guinn gained her B.Sc. in Genetics from the University of Wales, Aberystwyth in 1991 and a Ph.D. in Medicine from the University of Wales College of Medicine, Cardiff in 1995. Dr. Guinn was one of the first Leukaemia Research Fund Gordon Piller Ph.D. students in the year this prestigious award was initiated. Dr. Guinn undertook two postdoctoral fellowships at the University of Toronto (Autologous Bone Marrow Transplant Unit, Toronto General Hospital and Department of Immunology) and has received funding for her research from Leukaemia and Lymphoma Research, Cancer Research U.K., the Elimination of Leukaemia Fund, Wessex Cancer Trust and British Society for Haematology among others. Dr. Guinn has published over 50 peer-reviewed manuscripts. She is on the editorial board for a number of journals and reviews manuscripts for more than 30 scientific journals on an ad hoc basis. Research Interest
|  |
Texas Tech University, USA
| Biography Dr. Huazhong Shi received his PhD in Plant Developmental Biology from Wuhan University, China. He did postdoctoral research from 1999-2004 in University of Arizona, University of California at Davis, and Purdue University. Dr. Shi is currently an associate professor of biochemistry in the Department of Chemistry and Biochemistry at Texas Tech University. His research mainly focuses on the molecular mechanisms of plant abiotic stress response and tolerance. Dr. Shi’s works have been published in many highly respected journals such as Nature Biotechnology, PNAS, Plant Cell, PLoS Genetics, etc. Research Interest
|  |
Weill Cornell Medical College, New York, USA
| Biography Dr. David Warren received his undergraduate degree from Fort Lewis College, majoring in both Biochemistry and Cell & Molecular Biology. During an NSF-funded undergraduate summer research fellowship, studying under the late Professor Albert I. Meyers at Colorado State University, Dr. Warren confirmed his interest in the interplay between chemistry and biology. He then pursued a postgraduate degree in organic chemistry under the tutelage of Professor Yian Shi at Colorado State University, where he refined his synthetic skills by studying asymmetric oxidation reactions and their application to the synthesis of natural products possessing neurite outgrowth activity. Upon completion of his PhD, he moved to the Memorial Sloan-Kettering Cancer Center for a postdoctoral fellowship with Professor Samuel J. Danishefsky. While there, he studied the synthesis of glycopolypeptides, and their application as vaccines for cancer and HIV. Along the way, he developed key methodology that significantly advanced the field of glycoprotein synthesis. In 2006, he began his independent career at Weill Cornell Medical College as both Assistant Professor of Biochemistry, and inaugural Director of the Abby and Howard P. Milstein Chemistry Core Facility. He has since moved through the ranks to become Associate Research Professor of Biochemistry, while still directing the Milstein Chemistry Core Facility. Research Interest
|  |
University of Barcelona, Spain
| Biography Prof. Josep M. Argiles completed his undergraduate studies in Biology at the University of Barcelona. In 1981 he received his Doctorate in Biochemistry from the same university with Cum Laude obtaining the Prize for the best doctorate of that year. He then became Lecturer in Biochemistry and carried out postdoctoral work on acetone metabolism in mammals. He has authored and co-authored over 350 publications, including several books, many related to the field of cancer research. His department obtained the City of Barcelona Science Award in 1997. He has also filed several national and foreign –including U.S.-patents. In 1985 he obtained the Divulga Prize for his contributions to popular science. He reviews scientific articles for over 90 international journals. He is also an active advisor of several pharmaceutical companies in the field of Medical Nutrition, participating in several clinical trials involving anti cachectic molecules. Hewas the first scientist to describe the mechanism responsible for the increased protein breakdown in skeletal muscle of cancer patients which seems to be responsible for muscle wasting. He is responsible for the introduction of the concept of the cytokine balance of the cancer patient, the ratio of the pro-cachectic (TNF-alpha,IL-6,IFN..) to anti-cachectic (IL-10, sTNFRs….) cytokines. In addition to his work in describing mechanisms and mediators of cancer cachexia, Prof. Argiles has made interesting contributions in the form of pre-clinical studies regarding the pharmacological treatment of cachexia using different therapeutic startegies like anabolic cytokines, such as IL-15. Research Interest
|  |
Northumbria University, New Castle, England
| Biography Dr.Robert Finn is a Senior Lecturer in Biochemistry in the Department of Biomedical Science. Robert studied for his honours degree in biochemistry at University College Cork, Ireland and stayed to complete his PhD in biochemistry under the supervision of Prof. Mary McCaffrey, investigating small molecular weight G-proteins of the Rab family. On completion of his PhD he continued to work with Prof. McCaffrey on a project investigation post-translational processing of prion proteins. To further his research career, Robert moved to the University of Dundee in 2000, where he remained until taking up his post at Northumbria, working with Prof. Roland Wolf on cytochromes P450 and diflavin oxidoreductases. Research Interest
|  |
Dammam university , Egypt.
| Biography Dr. Kamal Adel Amin is currently working as a Professor of Biochemistry, Dammam University KSA. He had the honor and privilege of heading the biochemistry deptt. , Faculty of Veterinary Medicine, Beni-Suef, University, Egypt from 2008-2012. His expertise in this field has earned him the rank of editor and reviewer in several esteemed scientific journals. He is actively involved in training and developing the skills for the faculty at his university. He is also an articulate academician involved in developing and modernizing the biochemistry course-curriculum at the university. Dr. Kamal is an active member of several scientific societies. He diligently fulfils his CSR responsibilitiesand is involved with the program of continuous development and rehabilitation for community service and environmental development. Research Interest
|  |
Leeds Metropolitan University, UK
| Biography Dr. Duncan Sharp received his PhD in Analytical Biochemistry in 2009 from Nottingham Trent University on ‘The Development of Smart-Bandage Technologies’. He was Senior Lecturer in Biomedical Sciences (specialising in Clinical Biochemistry) at Leeds Metropolitan University from 2009-2013, and in 2014 promoted to Reader in Biomedicine and is now the Director and Co-founder of the Centre for Biomedicine Research.Dr Sharp’s expertise link together clinical biochemistry and the development of novel analytical methods and electro analytical sensors, with broad expertise in the development, assessment and validation of biomarker analysis for a range of clinical applications (laboratory, point of care and in-situ wound monitoring). His research into novel electro analytical methods for biochemical analysis has led to many publications, in journals such as: Biosensors and Bioelectronics, Electrochemistry communications and Bio electrochemistry. Aside from laboratory-based research, Dr Sharp is also interested in novel teaching practices for Biochemistry education and the engagement of undergraduate students in extra-curricular research. Dr Sharp is a member of The Association for Clinical Biochemistry and Laboratory Medicine, affiliate of the Royal Society for Chemistry, grant reviewer for the Engineering and Physical Sciences Research Council (EPSRC), and peer reviewer for multiple journals. Research Interest
|  |
Arizona State University, USA
| Biography Dr. Xiaobo Yu obtained his Ph.D. in 2006, and is an associate research scientist in the Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University. He has extensive knowledge in the High-Throughput (HT) gene cloning, plasmid repository construction, protein microarray technology and applications in the study of protein-protein interaction, protein-DNA interaction, post-translational modification as well as the discovery and validation of disease-related biomarkers. He has more than 30 publications in the fields of proteomics and analytical chemistry, including ACS Nano, Molecular & Cellular Proteomics, Clinical Chemistry, Theranostics, mBio, Analytical Chemistry, Scientific Reports, Proteomics and J Biological Chemistry, etc. He was honored as Alexander von Humboldt Fellow in Germany from 2008 to 2009 and obtained Young Investigator Travel Awards in the world and US HUPO (Human Proteome Organization) conferences. Research Interest
|  |
Institute of Molecular Biology and Biotechnology, Greece
| Biography Dr. Michalis Aivaliotisis currently a senior research scientist in protein biochemistry and functional proteomics at the Institute of Molecular Biology and Biotechnology (IMBB) and a visiting Assistant Professor at the Biochemistry Department of the University of Crete (Greece). He obtained his PhD in Chemistry in 2005, from the University of Crete in collaboration with the University of Johann Wolfgang Goethe (Germany), In recognition of excellence during his PhD, he received the prestigious and highly competitive fellowships from Alexander von Humboldt foundation and Max-Planck Society for post-doctorate research in the Max Planck Institute (MPI) of Biochemistry, (Germany), and in the Institute of Pharmaceutical Chemistry of the University of Johann Wolfgang Goethe (2005-2008). He has reviewed for several scientific journals including Journal of Chromatography B, Journal of Proteome Research, Antioxidants & Redox Signaling, Bioinformatics, Proteomics, Translational Medicine; for two international grant agencies; and for several evaluation/recruitment committees. He is a member of ten scientific societies (including FEBS, ACS, ASMS, ASBMB) and he has organized a plethora of international meetings and training workshops. Moreover, he has given many invited lectures at international conferences and universities and he has supervised and trained many junior scientists. Research Interest
|  |
Autonomous University of Barcelona, Spain
| Biography Dr. Salvador Ventura is Full Professor and Head of the Protein Folding and Conformational Diseases Laboratory at Universitat Autònoma de Barcelona. Work at his lab focuses on protein folding, misfolding and amyloid formation, with special emphasis on their impact on protein homeostasis and conformational disorders. He has contributed with more than 120 research articles to these topics. He has been a postdoctoral fellow at EMBL-Heidelberg and visiting scientist at Harvard Medical School (US) and Karolinska Institutet (Sweden). Research Interest
|  |
University of Hawaii Cancer Center, Hawaii, USA
| Biography Dr. Vishal Singh Negi is a Postdoctoral Researcher at the University of Hawaii Cancer Center, Hawaii, USA. He obtained his undergraduate degree with honors in Biotechnology in 2001 from Ranchi University, India followed by MS degree in Biotechnology in 2003 from HNBG University (a Central University). In 2004, he joined Indian Council of Agricultural Research (ICAR) as a Senior Research Fellow and worked on a Department of Biotechnology sponsored project for 2.5 years. He then obtained the prestigious and competitive Ford Foundation International Fellowship for pursuing PhD in Molecular Biosciences as a result he joined the Borthakur lab in the Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa. Under Prof. Dulal Borthakur’s supervision he got extensive research experience in the field of biochemistry and molecular biology. His PhD was focused on studying the metabolic pathways involved in the metabolism of mimosine, a secondary metabolite from Leucaena. Having been awarded his Ph.D. degree in 2012, he joined University of Hawaii Cancer Center as a postdoctoral fellow, where he has been working on the biochemistry of mesothelioma progression. Research Interest
|  |
Houston Methodist Research Institute, Houston, USA
| Biography Dr. Sengupta earned his Ph.D. in Life Sciences from Jadavpur University, India in 2008. He then joined University of Texas Medical Branch at Galveston for postdoctoral training as a Visiting Scientist and was later promoted to Research Scientist in 2012. He received Gulf Coast Consortia’s Computational Cancer Biology Training Program Fellowship Award in 2011 from the Keck Center, funded by Cancer Prevention and Research Institute of Texas. He is a recipient of Young Scientist Award from Indian Society of Human Genetics in 2007. As a member of the Cancer Research Program in the Department of Radiation Oncology, Dr. Sengupta works in Dr. Sankar Mitra’s group and works on genome damage repair associated with transcription regulation in cancer. He is also a member of American Association of Cancer Research and Indian Society of Human Genetics. Research Interest
|  |
Chinese University of Hong Kong., Hong Kong
| Biography Dr. Kwok-Fai Lau obtained his B.Sc. and Ph.D. degrees from the Hong Kong Baptist University and the Chinese University of Hong Kong respectively. After finishing his PhD, he relocated to the Institute of Psychiatry, London, UK as a research fellow. In 2007, he was appointed assistant professor in Biochemistry at his Alma mater. He is now Associate Professor in the School of Life Sciences at the Chinese University of Hong Kong. Research Interest
|  |
Sunderland University, sunderland, UK
| Biography Dr. Nicolas Haroune is a senior lecturer in Analytical Chemistry and Clinical Biochemistry in the Department of Pharmacy, Health and Well-being of Sunderland University. Nicolas obtained his PhD in France in 2003, studying the biodegradation of organic pollutants by microorganisms using in situ 1H NMR. He then completed a postdoctoral project at Glasgow University, investigating protein modification during oxidative stress before taking up the managerial role of chemiSPEC in 2005 at Sunderland University, offering LC/NMR and LC/MS contract services to industry. Research Interest Dr. Nicolas Haroune research interest includes "Application of NMR and MS based metabolomics in the field of prostate cancer, cystinosis and sport sciences". |  |
Baylor College of Medicine, Houston, USA
| Biography Dr. Sandeep Kumar did his PhD from Center for DNA Fingerprinting and Diagnostics (CDFD) India in 2010 with prestigious CSIR-JRF/SRF fellowship from the Indian government. At CDFD, he discovered his passion for DNA replication and recombination and learned various in-vitro DNA replication techniques. After completing his PhD he joined the laboratory of Dr. Peter Burgers as a Postdoctoral Scientist (2010-2012) and worked on DNA replication checkpoint in budding yeast. In Dr. Burgers laboratory his major research objective was to identify proteins that stimulate Mec1 (human ATR) kinase and to characterize their ATR activation domain (AAD). Here he was able to show that Dna2 connects DNA replication-to-replication checkpoint. Further, it showed that Dpb11 (human TopBP1) is not S-phase specific checkpoint activator. This is a major discovery in the field of DNA replication checkpoint as for many years it was thought that Dpb11 is the principal S-phase specific checkpoint activator. To further his studies on DNA repair and recombination he joined the Dr. Gregory Ira’s lab (2013-current) at Baylor College of Medicine. Here he is trying to understand the molecular mechanism of double strand break repair and how the defects in DNA damage checkpoint lead to development of cancer. Research Interest Dr. Sandeep Kumar research interests include "Genome Instability, Cancer Biology, Double Strand Break Repair, DNA Replication, Epigenetics, Evolution". |  |
Baylor College of Medicine, USA
| Biography Dr. Rituraj Pal, a postdoctoral research associate at Baylor College of Medicine has done Doctor of Veterinary Medicine from India, Masters in Chemistry and PhD in Biochemistry from University of Texas at El Paso, USA. He received prestigious George Krutilek Memorial Scholarship during his PhD. He is a member of Veterinary Council of India. He is a member of Biophysical Society .He has more than eight years of research experience in the field of Biochemistry, Biophysics and Molecular Biology as exemplified by his publications in several reputed peer-reviewed journals such as Nature Communications, Plos One, FEBS Lett, Biochemistry, etc. He reviewed more than 15 journals published by Dove press and Wiley publishing groups. Research Interest
|  |
National University of Singapore, Singapore
| Biography Dr. Wen Shan is a biochemist/molecular biologist and mechanistic enzymologist. He is currently an Assistant Professor in the Department of Biochemistry, Yong Loo Lin School of Medicine, at the National University of Singapore. He obtained his PhD (2004) from the University of Illinois at Urbana-Champaign (UIUC). He has worked with John Gerlt to delineate the evolution of enzymatic activities by divergent evolution; in particular, he defined a third mechanism of enzymatic evolution, that of the opportunistic Nature of conservation of active site architecture, represented by the discovery of the orotidine 5’-monophosphate decarboxylase suprafamily. Research in the Yew lab is currently centred on expanding the multi-faceted interface between enzymology and biological chemistry; his group is interested in defining the use of Synthetic Enzymology for biomedical and bioremediation applications, in the rational design and directed evolution of enzymatic activities, deciphering enzyme specificities, discovery of new enzymatic functions, mechanistic enzymology of enzymes of pharmaceutical importance, and drug design and therapeutic development against infectious diseases, cancer and ageing. He was an A*STAR International Fellow (2002), Herbert E. Carter Fellow in Biochemistry (2002), and was a recipient of the Singapore National Academy of Science Award in Biochemistry (1998), and the Biochemistry Trust of Urbana Award (2006) from UIUC. Research Interest
|  |
Northwestern University, Chicago, USA
| Biography Dr. Zheng is an Associate Professor in the Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine of Northwestern University, Chicago, USA. She also holds joint appointments in the Interdepartmental Neurosciences Program and Department of Communication Sciences and Disorders. Dr. Zheng is a Fellow of the Hugh Knowles Center for Hearing Research. She received her Ph.D degree from Michigan State University, USA. She has published more than 40 papers in peer-reviewed research journals and serving as editorial board members for several journals. The goal of her research is to identify and investigate molecules that play important roles in mammalian hearing, thus to enrich our understanding of cochlear physiology, and to further develop a better strategy to prevent hearing loss. Currently, the research efforts of Dr. Zheng’s laboratory are focused to on understanding the molecular mechanism of several deafness-related proteins including voltage-driven motor protein prestin, adhesive protein CEACAM16, calcium-binding protein oncomudulin, and several microtubule-associated proteins using various cellular, biochemical and molecular biological methods. Research Interest
|  |
Washington State University, Pullman, Washington, USA
| Biography Dr. Jonel P. Saludes is an Assistant Professor of Chemistry at Washington State University. He graduated from University of San Agustin, Iloilo, Philippines with a degree in Chemistry (Cum Laude) and earned his Master of Science in Chemistry from the Royal and Pontifical University of Santo Tomas, Manila (Summa Cum Laude). He was awarded a fellowship by UNESCO Regional Network for the Chemistry of Natural Products in Southeast Asia and trained under the tutelage of Prof. Mary J. Garson at University of Queensland, Brisbane, Australia. He joined the laboratory of Prof. Jacquelyn Gervay-Hague at University of California Davis to complete his doctoral studies in organic chemistry. Using extensive NMR spectroscopic techniques and circular dichroism, he studied chimeric alpha-delta and delta-delta linked peptides that were designed as surrogates of polysialic acid. His work elucidated the first solution phase three-dimensional helical structures and described the in vitro blood plasma stability of these novel peptides that helped establish the fundamental principles for sialic acid-based anticancer vaccine design. Dr. Saludes pursued postdoctoral training in chemical biology at University of Colorado Boulder under the supervision of Prof. Hubert Yin and designed synthetic peptides that sense highly curved lipid membrane bilayers for detecting exosomes and microvesicles, secreted extracellular lipid vesicles that play a significant role in intercellular signaling and cancer metastasis. His current research interests focus on the design of peptides as molecular probes, with strong emphasis on peptide-lipid interactions for drug delivery and biomarker discovery. Research Interest
|  |
Sunderland University, UK
| Biography Dr. Stephany Veuger is senior lecturer in clinical biochemistry and she was contributing to the biomedical sciences, biopharmaceuticals and pharmacy programmes at Sunderland. Previously, she held posts as an associate lecturer at Northumbria university teaching on the biomedical sciences programme and the Open University where she taught on a range of modules and continue to tutor the MSc in medicinal chemistry. She was visiting practitioner on the global scholars programme, St Georges University Grenada, teaching medical biochemistry and genetics and was e-learning developer at Newcastle University, successfully redeveloping modules within the MSc oncology and palliative care programme. Research Interest
|  |
University of Minnesota, USA
| Biography Dr. Shrawan Mishra has done his PhD in the field of Genomics and Biochemistry from Jawaharlal Nehru University (JNU), New Delhi, India. He was a member of Indian genome variation consortium that was involved in identifying and analyzing single nucleotide polymorphisms (SNP) involved in the protection/predisposition of Plasmodium falciparum malaria in Indian subpopulations. He is currently working at Hormel institute, University of Minnesota since 2010. His current projects deal with molecular and cell biological studies of glycolipid binding and transfer proteins. He has 37 international peer reviewed publications in reputed journals like Nature, Clinical Cancer Research, Cancer Metastasis Review, Plos One, Malaria journal, Human Genetics. Dr. Shrawan is an associate member of American Association of Biochemistry and Molecular Biology and has served as the editor for “Pinnacle”. He also has the distinction of reviewing several manuscripts for journals like Oncotarget and Therapy/ Infection and Drug Resistance/American Journal of Biomedical Sciences. Research Interest
|  |
University of Minnesota, USA
| Biography Dr. Puja Singh is a Post Doctoral Research Associate working at The Hormel Institute, University of Minnesota, USA. She had more than eleven years of research experience in the field of Biochemistry, Biophysics and Molecular Biology as exemplified by her publications in several reputed peer-reviewed journals such as JBC, EMBO Journal, Molecular pharmacology, Journal of Neuroscienceetc. She listed as reviewer in journals like Drug Design, Development and Therapy published by the Dove press. Research Interest
|  |
University of Ottawa, USA
| Biography I started my research career developing antibody responses to hormones during my Ph.D. at the National Institute of Immunology, New Delhi. We showed that tolerance to self-molecules can be easily broken by conjugating them to immunogenic proteins. We developed antibody responses against numerous hormones based on this technology and showed that the antibody response against Gonadotropin releasing hormone (GnRH) resulted in atrophy of the prostate, and hence was used successfully as a therapy in androgen-dependent prostate cancer patients. During this time I also showed that T cells are critical in facilitating help for generation of antibody responses to hormones. Having realized the important role T cells play in acquired immunity, I then relocated to the University of Alberta, Edmonton, Canada to work with Dr. Tim Mosmann as a post-doctoral fellow. We showed that distinct cytokine-secreting subsets of CD4+ T cells are derived from a common precursor cell that secretes mainly IL-2. My studies further demonstrated that CD8+ T cells can secrete distinct cytokine patterns which can influence their function. I also showed that cytokines can induce a state of “anergy” in T cells, providing novel mechanistic insights into how cytokines might regulate T cell responses in vivo. I was supported by a post-doctoral fellowship from the Alberta Heritage Foundation for Medical Research and I was able to publish my results in various high impact journals. In 1997, I moved to the National Research Council of Canada, Ottawa as an independent investigator. During this time I set up various infection models to discern the molecular mechanisms of host pathogen interactions. I set up numerous collaborations, published in various high impact journals regarding the development of T cell memory responses against acute and chronic intracellular bacterium. In 2013, I moved to the University of Ottawa, Department of Biochemistry, Microbiology and Immunology, as a full professor to continue my research work in the general area of host pathogen interactions. My research has been continuously funded by the Canadian Institutes of Health Research and various other provincial and industrial research organizations. I have also lead large, diverse research teams with the intention of developing solutions through translational research. Research Interest
|  |
University of Puerto Rico, USA
| Biography Research Interest |  |
Purdue, USA
| Biography Dr. Humaira Gowher is currently working as a Assistant Professor in the Dept.of Biochemistry, Purdue university.Her area of expertise was Regulation of DNA methylation in development and disease. She revealed certain facts about the newly discovered enzymes in genetic material. And thereby,she paved a way for anti-cancer medicines and published with 22 reputed international journals. She did her post-doctorate degree at National Institute of Health (NIH). Research Interest Regulation of DNA methylation in development and disease |  |
University of New Mexico, USA
| Biography Dr. Hu was trained as a human geneticist and biochemist at Johns Hopkins Medical Institutes and has published peer-reviewed papers in ROS generation, apoptosis, and autophagy in human diseases, including atherosclerosis, end stage kidney disease, and cancer. In 2004, his laboratory pioneered the cloning and characterization of human apolipoprotein L6 (ApoL6), which, when overexpressed, induced mitochondria-mediated apoptosis in cancer cells. In addition, Dr. Hu’s team also identified and characterized ApoL1, another member of the same family, which, when overexpressed, induced autophagy and Atg5 and Atg7-dependent cell death. His team has recently demonstrated that ApoL6 is an important factor regulating both mitochondria-mediated apoptosis and Beclin 1-dependent autophagy in atherosclerosis. Thus, the cell-based models of ApoL6-induced apoptosis and ApoL1-induced autophagy are useful for further dissecting the molecular bases of cell death and survival and for screening small molecules/drugs that can target apoptosis and autophagy.Dr. Hu’s team also continue studying the function of proline metabolic enzymes in human health and disease.
Research Interest
|  |
Urmia University of Medical Sciences , Iran
| Biography Dr.Yousef Rasmi is a Clinical biochemist involved in both teaching and research and currently working as a lecture and Associate professor at Department of Clinical Biochemistry at Urmia Medical Sciences University (UMSU), Urmia, Iran.He is the editor in cheif for AJMS journal and also works as a editor for 9 more journals. Research Interest
|  |
University of California, USA
| Biography Dr.Bharat Jagannathan is currently working as post doctoral research assistant at University of California and completed his PhD at Pennsylvania State University. He is also working as a editor for many international journals. Research Interest
Expertise in a wide range of proteins including soluble recombinant proteins, proteins expressed as inclusion bodies, native membrane proteins, light-sensitive and oxygen-sensitive proteins
Large-scale expression of (un)structured proteins and proteins encoded by rare codons in a variety of bacterial host strains Protein Purification Techniques: Ion-exchange chromatography, affinity chromatography, size exclusion chromatography, high-throughput HPLC, FPLC, density gradient ultracentrifugation Analytical Techniques: Protein quantitation assays, gel electrophoresis, western blotting, analytical ultracentrifugation, steady-state enzyme kinetics, gas chromatography, microcalorimetry Biophysical Techniques: Fluorescence spectroscopy, FRET assays, UV-Vis absorption spectroscopy, circular dichroism, time-resolved optical spectroscopy, Electron Paramagnetic Resonance (EPR) spectroscopy, single-molecule force spectroscopy with optical tweezers, dynamic light scattering Molecular Biology Techniques: primer design, PCR, gene cloning, and site-directed mutagenesis Other Relevant Skills: protein crystallization, enzyme engineering, site-specific labeling of proteins |  |
Hassan II University Casablanca, Morocco
| Biography Ainane tarik is an analytical chemist, working as a Professor in Hassan II University, he completed his PhD in Analytical Chemistry, and has been the winner of the Faculty of Science ben Msik University Hassan II in 2011, he did thesis on: "recovery of algal biomass Morocco: potential pharmacological and environmental applications where brown algae Bifurcaria bifurcata and Cystoseira tamariscifolia. " Ainane Tarik specialized all the techniques and instrumentation in analytical chemistry like spectroscopy, chromatography, etc. and had an interesting background in the field of microbiology, he published articles in national and international reviewed journals. His articles are involved in tens Congress by poster or oral communications; it also carries a patent entitled "use of products extracted from marine algae Bifurcaria bifurcata in the treatment of leishmaniasis" Research Interest
|
North-Eastern Hill University, India
| Biography Dr.Timir Tripathi is currently working as a Assistant Professor in the Dept.of Biochemistry, North-Eastern Hill University. His area of expertise was Molecular biophysics, Biotechnology, Structure-folding-function-stability relationship of proteins and he also works as an editor for many journals like Scientific Journals International (SJI) and Advances in Applied Research etc. He did his post-doctorate degree at Jawaharlal Nehru University. Research Interest
|  |
Industrial Waste Water Research Lab Division of Applied & Environmental Microbiology Enviro Technology, India
| Biography Dr. Maulin P Shah, currently Chief Scientist & Sr.Manager – Industrial Waste Water Research Lab, Division of Applied & Environmental Microbiology Lab at Enviro Technology Limited, Ankleshwar-393002, Gujarat, India got his Ph.D in Environmental Microbiology from Sardar Patel University, Vallabh Vidyanagar, Gujarat. He has served as an Assistant Professor at Godhra,Gujarat University in 2001. Dr. Maulin P Shah is a Microbial Biotechnologist with diverse research interest. A group of research scholars working under his guidance on areas ranging from Applied Microbiology, Environmental Biotechnology, Bioremediation, and Industrial Liquid Waste Management to solid state fermentation. His laboratory is trying to assess the impact of industrial pollution on microbial diversity of waste water following cultivation dependant and cultivation independent analysis. His major work involves isolation, screening, identification and Genetic Engineering of high impact of Microbes for the degradation of hazardous materials. Dr. Maulin P Shah has more than 120 research publication in highly reputed national & international journals. He has completed one research projects in 2010 in his lab, funded by National Agency. He directs the Research programme at Enviro Technology Ltd, Ankleshwar. He has guided more than 20 Post Graduate students in various disciplines of Life Science. Dr. Maulin P Shah extends his expertise in various National as well as International Reputed Journal as Editor& Editorial Board Member like Open Access Book of Cloud Publication, Journal of Environment Pollution & Human Health. He was founder Editor-in-Chief (2012-2014) of two journals viz.International Journal of Environmental Bioremediation & Biodegradation as well as Journal of Applied & Environmental Microbiology (Science & Education Publishing., USA), Editorial Board Member of American Journal of Microbiological Research (2012-2014), Electronic Journal of Energy & Environment, International Journal of Environment & Sustainability. He is also serving as a Reviewer in various journal of National & International Repute Research Interest
|  |
University of Connecticut, USA
| Biography Dr. Matthew Ranaghan received his Ph.D. in Biochemistry from the University of Connecticut in 2011. Part of his thesis work was used in a patent that helped start Lambda Vision, Inc., which seeks to develop protein-based prosthetics to treat visual disorders. He then pursued a postdoctoral fellowship at Brandeis University (2011-2015) before joining the Broad Institute of MIT and Harvard as a Research Scientist in 2015. He has published 10 peer-reviewed research papers and contributed to one US patent. His areas of expertise include molecular biology, protein purification, biochemistry, and biophysics. Research Interest
|  |
Istanbul Technical University , Turkey
| Biography Dr. Ramin Ekhteiari Salmas received his Ph.D. degree in physical chemistry from Istanbul Technical University in 2014. Dr. Salmas is a researcher in computational biochemistry and pharmacology and also with an interest in computer programing. Salmas's researches focus on protein modeling, computer-aided drug design, three-dimensional quantitative structure-activity relationships (3D-QSAR) analysis, molecular dynamics (MD) simulation and developing and scripting new methods. Dr. Salmas uses the molecular modeling and chemo informatics to discover new highly potent drugs against cancer and psychotic disorders. His investigations have been published in peer-reviewed journals. Research Interest · Membrane proteins. · G-protein-coupled receptors (GPCRs). · Dopamine D2 receptor and inhibitors. · Anti-psychotic drugs. · Anti-cancer drugs. · Carbonic anhydrase inhibitors. · C-C chemokine receptor type 5 (CCR5). · Antiretroviral drugs. |  |
California South University (CSU), USA
| Biography Dr. Alireza Heidari, Ph.D., D.Sc. is a Postdoctoral Research Fellow in Chemistry. He has got his Ph.D. and D.Sc. degrees form California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management and also in Nanochemistry and Molecular Structure Theory. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods. He has participated at more than fifty reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Index (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Netherlands, Russia, France, Swiss, Germany, Sweden, Spain, Portugal, South Korea, China, etc. as research fellow, sabbatical and volunteer researcher or visitor heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than ten books in Chemistry. Syne, he has been awarded more than four hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals. Hitherward, he is a member of more than one hundred reputed international academic–scientific–research institutes around the world. Research Interest
|  |
Universidad Nacional de San Luis, Argentina
| Biography Dr. Carlos R. Pungitore has a Ph.D. inBiochemistry. He has different postdoc stays inUniversities from Spain (University of La Laguna)andGermany (University of Göttingen and Tübingen).Also, he has publicated26 scientific articles and books about natural products and organic compounds with their bioactivity. Actually, He is a Researcher in National Council of Science from Argentine (CONICET) and he is Director of different Projects and Subsidies. Research Interest Dr. Carlos R. Pungitore is interested about natural products andnon-nucleoside compounds with the ability to inhibit enzymes that play acrucial role in DNA metabolism such as replication, transcription, retro transcription, recombination, and chromosome segregation during mitosis.The focus is placed on DNA polymerases, topoisomerases and reversetranscriptase inhibitors because most of the literature emphasized on theinhibitory action of these compounds. A great diversity of chemicalcompounds encompassing triterpenes, flavonoids, chromones, lipids,iridoids, phytosterols, coumarins, anthracyclines, quinones, protoberberines, tannins, lignans, acetogenins, benzimidazoles and othernatural products have inhibitory activities against enzymes related to DNA metabolism allowing that theseenzymes surge as important molecular targets for cancer and AIDS research. | .jpg) |
The University of Oklahoma Health Sciences Center, United States
| Biography I am a Post-Doctoral Fellow in Dr.Queimado’slab at the University of Oklahoma Health Sciences Center. My goal is to elucidate the molecular mechanisms by which combustible tobacco and electronic nicotine delivery devices might contribute to cancer risk. I have previously reported that exposure to a single puff of active or secondhand smoke causes significant DNA damage. These data are essential to guide tobacco prevention. Currently I am studying the molecular mechanism underlying electronic cigarette (EC) induced DNA damage on oral epithelial cells collected from EC users, before and after vaping. My studies will reveal the effects EC power (voltage), flavors, metabolites, and lifestyle on DNA damage. We are also studying the effects of tobacco smoke and EC aerosols on normal, premalignant and cancer cells. These will be of great clinical importance since cells undergo drastic changes during oncogenesis. Our studies will aid in designing better preventive and screening strategies and will decrease the burden to tobacco-associated diseases and health costs in Oklahoma and worldwide. I have over 14 years of experience in biomedical research, 12 of which in the field of DNA damage, oxidative stress and antioxidant defense mechanisms. I have been working as an independent researcher for the last 6 years and I have trained and mentored many students and research scholars. I aim to establish my own laboratory and to continue to use my expertise to characterize the impact of tobacco and other nicotine delivery devices on human cancer, with the ultimate goal of improving cancer prevention and therapeutics.
Research Interest Head and neck Cancer, DNA damage and repair, Oxidative stress, Total antioxidant capacity, TP53 gene, Genotoxicity and Cytotoxicity, Endocrinology, Reproductive Toxicology, Environmental Toxicology,Biomarkers,Tobacco smoke,Electronic cigarette |  |
, Syria
| Biography Loai Aljerf is a Prof in the Department of Basic Sciences, Faculty of Dental Medicine/DamascusUniversity. He is a specialist in analytical and industrial chemistry. He obtained many awards and published more than 50 peer-reviewed papers (two of them in French) in Environmental Sciences, Green Chemistry, Analytical Chemistry, Synthesis Chemistry, Concrete, Ceramics, Paper Industry, Petrochemical, Extraction, Separation, Lithium-Ion-Batteries, and Oral Chemistry. He is a partner in Advances in Cleaner Production Network, and a member of the German Chemical Society e.V. (GDCh),Asian Chemical Society,and the American University of Beirut. He is a member of the higher committee of the 6th International Workshop-Advance in Cleaner Production (São Paulo, Brazil (May 24th to 26th - 2017)) and in more than 20 conference organizing committees. Loai Aljerf is in the Cambridge Scholars Publishing-Life Science Advisory Board and an editor of more than 50 journals and a reviewer for Top journals in Industry, Chemical Engineering, and Environmental Chemistry. Research Interest Industrial Chemistry, Analytical Chemistry, Environmental Chemical Engineering, Environmental Science, Environmental Chemistry, Green Chemistry, Cement Industry, Ceramics, Paper Industry, Advances in Cleaner Production, Climate Change, Pollution, Wastewater Treatment, Air Pollution, Eco-friendly Biopolymers, Persistent Organic Pollutants, Polychlorinated biphenyls,Polycyclic Aromatic Hydrocarbons, Nanotechnology,Adsorption, Ecology and Natural Resources, Biodiversity, Sustainable Development, Waste Management, Environmental Management, Life Cycle Assessment, Ecodesign, Design for the Environment, Energy Labeling, Eco-efficiency, Chromatography, HPLC, GC, MS, AAS, Spectroscopy, and Lithium-Ion-Batteries. |
